Angshumoy Roy, MD, PhD
- Pathology
Molecular Pathology, Associate Professor, Pathology and Immunology and Pediatrics, Baylor College of Medicine
Phone:
832-824-3710
Languages: English
Departments:
Office location:
1102 Bates Avenue
Suite 830
Houston, TX 77030
Get to know Angshumoy Roy, MD, PhD
Dr. Angshumoy Roy's clinical interests encompass the application of molecular genetic and genomic technologies in the diagnosis of cancer and in the identification and development of biomarkers that predict chemoresistance. His research interests involve exploring the genomics and epigenomics of embryonal cancers. A special area of interest is the study of CpG methylation alterations in hepatoblastoma and other pediatric solid tumors. Cytogenomic arrays, next-generation seq technologies, sodium bisulfite sequencing are used to characterize the genomic and epigenomic landscapes of embryonal cancers.
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Baylor College of Medicine | Fellowship | Molecular Genetic Pathology | 2012 |
| Baylor College of Medicine | Residency | Anatomic and Clinical Pathology | 2011 |
| Baylor College of Medicine | Research Fellowship | Research Fellowship | 2007 |
| Baylor College of Medicine | PhD | Doctor of Philosophy | 2006 |
| Bangalore Medical College | Research Fellowship | Research Fellowship | 2001 |
| University of Calcutta | Internship | Pathology | 1999 |
| University of Calcutta | Medical School | Bachelor of Medicine & Surgery | 1999 |
Organizations
| Organization Name | Role |
|---|---|
| American Society for Clinical Pathology (ASCP) | Member |
| Association for Molecular Pathology | Member |
| Association of Indian Pathologists in North America | Molecular Pathology Executive Committee Member; Resident Abstract Award Committee Member |
| College of American Pathologists | Member |
| United States and Canadian Academy of Pathology | Member |
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Highlights
CAR T cell therapy for pediatric brain cancer warrants further study
BCM.eduMagoulas PL, El-Hattab AW, Roy A, Bali DS, Finegold MJ, Craigen WJ. Diffuse reticuloendothelial system involvement in type IV glycogen storage disease with a novel GBE1 mutation: a case report and review. Human Pathology 2012 Jun;43(6):943-51.